The Motley Fool
05 Jul 2026, 13:15 UTC · 2h ago
Fidelity Health Care vs. State Street Biotech: Which ETF Fits Your Portfolio Best?
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
The Motley Fool
05 Jul 2026, 13:15 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
The Fidelity MSCI Health Care Index ETF (FHLC) offers broad U.S. healthcare exposure with high concentration in mega-caps like Eli Lilly (14%) and Johnson & Johnson (8.95%). — Heavy weighting in these specific pharmaceutical giants means FHLC performance is strongly tied to a few systemic healthcare winners.
+0.20The State Street SPDR S&P Biotech ETF (XBI) utilizes a modified equal-weighted approach focusing exclusively on the higher-volatility biotechnology subsector. — The equal-weighted structure makes the fund more sensitive to mid-cap biotech swings than to a few industry leaders.
+0.10FHLC provides a significantly higher dividend yield (1.3%) compared to XBI's yield (0.4%). — This reflects a fundamental difference in investor profile (income-seeking vs. growth-seeking) but is a low-impact driver for overall price movement.
+0.05Which stocks this story touches
Continue reading
6 related stories
Top 2 movers · tap to explore
Mentioned only as a top holding in the Fidelity MSCI Health Care Index ETF.
Mentioned only as a top holding in the Fidelity MSCI Health Care Index ETF.
Mentioned only as a top holding in the Fidelity MSCI Health Care Index ETF.
Mentioned only as a top holding in the SPDR S&P Biotech ETF.
Mentioned only as a top holding in the SPDR S&P Biotech ETF.
Mentioned only as a top holding in the SPDR S&P Biotech ETF.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
The Motley Fool
10h ago
